Summit Pharma axes Duchenne drug after Phase 2 failures
June 28, 2018Research and Development Duchenne Muscular Dystrophy, Summit Pharmaceuticals, pharma, trial failure
Summit Therapeutics has revealed it is to terminate development of its Duchenne muscular dystrophy (DMD) drug ezutromid after it failed …
Roche’s Alecensa secures NICE approval in NSCLC after topping Pfizer’s Xalkori
June 28, 2018Sales and Marketing Alecensa, NICE, NSCLC, Pfizer, Xalkori, pharma
UK health watchdog NICE has given its approval for Roche’s selective ALK inhibitor Alecensa (alectinib) for use on the NHS, …
Amgen biosimilar proves non-inferior to J&J’s Remicade in rheumatoid arthritis
June 27, 2018Research and Development, Sales and Marketing Amgen, Johnson & Jonson, Remicade, pharma, rheumatoid arthritis
Amgen has unveiled new Phase 3 data for its biosimilar version of Johnson & Johnson’s Remicade (infliximab), confirming that it …
US hospital’s ketamine study forced to a halt over consent concerns
June 27, 2018Research and Development Hennepin Healthcare, Ketamine, pharma
Minneapolis-based hospital Hennepin County Medical Center has put the brakes on a clinical trial investigating the efficacy of ketamine in …
Abbvie and Google’s Calico extend age-related disease partnership to $2.5bn
June 27, 2018Research and Development, Sales and Marketing AbbVie, Cancer, Goggle, calico, pharma
The partnership of Abbvie and Google’s Calico has announced they are to extend their existing 10-year drug discovery and development …
AstraZeneca’s Lynparza proves efficacy in first-line BRCA-mutated advanced ovarian cancer
June 27, 2018Research and Development, Sales and Marketing AstraZeneca, Cancer, MSD, Merck, ovarian cancer, pharma
AstraZeneca is celebrating alongside partner MSD with the reveal of new data on the use of Lynparza in the first-line …
FDA panels vote to reject Pain Therapeutics’ abuse-deterrent opioid drug
June 27, 2018Research and Development, Sales and Marketing Remoxy, opioid crisis, opioids, pain therapeutics, pharma
Drug development firm Pain Therapeutics has revealed that its abuse-deterrent opioid medication Remoxy has been rejected by an FDA advisory …
Roivant launches two new companies amid major restructure and staff layoffs
June 26, 2018Manufacturing and Production, Research and Development Roivant, pharma
Roivant, the global biopharmaceutical firm spearheaded by founder and CEO Vivek Ramaswamy (pictured), has announced it is to undergo a …
Boehringer injects €230 million in new Biologicals Development Center
June 26, 2018Manufacturing and Production Boehringer Ingelheim, biologics, manufacturing, pharma
Prominent industry player Boehringer Ingelheim has unveiled plans to invest €230 million into the construction of a new Biologicals Development …
NHS “below average” in treating eight most common causes of death, report says
June 26, 2018Manufacturing and Production, Medical Communications NHS, pharma
The NHS’s 70th birthday is again marked as a bittersweet one as a new report from the Nuffield Trust highlights …
Pfizer’s Ibrance combo fails to improve overall survival in HER2- metastatic breast cancer
June 26, 2018Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, Faslodex, Pfizer, breast cancer, ibrance, pharma
Pfizer has stumbled with the reveal of new data on the efficacy of its oral CDK 4/6 inhibitor Ibrance (palbociclib) in combination …
Sanofi’s Toujeo proves non-inferior to insulin degludec in type 2 diabetes
June 26, 2018Manufacturing and Production, Research and Development, Sales and Marketing American Diabetes Association, Sanofi, diabetes, insulin glargine, pharma, toujeo, type 2 diabetes
Sanofi took the opportunity at the American Diabetes Association (ADA) 78th Scientific Sessions in Florida to unveil new data on …
GW Pharma’s Epidiolex becomes first cannabis-based medicine available in US
June 26, 2018Manufacturing and Production, Sales and Marketing FDA, GW Pharma, Lennox-Gastaut syndrome, UK, US, cannabidiol, cannabis
In what could prove to be a pivotal decision, UK biotech GW Pharmaceuticals has announced that its oral cannabidiol solution …
Working Life: Vertex Pharma’s Simon Lem, VP, Regional General Manager of North Europe
June 25, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Vertex, Vertex pahrma, Working Life, feature, pharma
Pharmafocus caught up with Vertex Pharma’s Simon Lem to discuss his journey throughout the industry and the importance of the …
European Commission greenlights Gilead’s Biktarvy for HIV-1
June 25, 2018Sales and Marketing Biktarvy, EU, Europe, European Commission, HIV, HIV-1, pharma
Good news for Gilead and HIV patients across the European Union today as the prominent pharma firm announced that its …
Sophiris halts cancer study after patient death
June 25, 2018Research and Development, Sales and Marketing Cancer, Sophiris, pharma, prostate cancer
Another clinical trial has been forced to a standstill as biotech firm Sophiris revealed that a patient death had prompted …
Eli Lilly’s dulaglutide doses show blood control and weight benefits at Phase 2
June 25, 2018Research and Development, Sales and Marketing Eli Lilly, Trulicity, diabetes, pharma
Eli Lilly has announced new data on its once-weekly, injectable glucagon-like peptide Trulicity (dulaglutide 1.5mg) and investigational 3.0 and 4.5mg …
J&J’s second-in-command to retire, alongside executive restructure
June 25, 2018Medical Communications, Sales and Marketing J&J, JJ, Johnson & Johnson, pharma
Johnson & Johnson’s Group Worldwide Chairman Sandra Peterson (pictured) has announced she is to retire from her role and the …
Roche’s Tecentriq combo extends life in untreated lung cancer
June 25, 2018Research and Development, Sales and Marketing Cancer, Roche, lung cancer, pharma, tecentriq
Roche has unveiled new data on the efficacy of Tecentriq (atezolizumab) in combination with chemotherapy (carboplatin and etoposide) for the …
Top Ten most popular articles on Pharmafile.com this week
June 22, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing pharma, top ten
The sun is out in the UK, it’s Friday, and the July/August issue of Pharmafocus is going to print. And, …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
